The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Janes, Daniel Peter
    Accountant born in September 1987
    Individual (3 offsprings)
    Officer
    2015-06-16 ~ dissolved
    OF - director → CIF 0
  • 2
    Davis, Mark James
    Director born in September 1975
    Individual (10 offsprings)
    Officer
    2015-06-16 ~ dissolved
    OF - director → CIF 0
Ceased 3
  • 1
    Broadbent, Gillian, Dr
    Biotech Consultant born in May 1971
    Individual (2 offsprings)
    Officer
    2015-06-16 ~ 2019-02-20
    OF - director → CIF 0
  • 2
    Charlton, Keith Alan, Dr
    Biotech Consultant born in April 1962
    Individual (6 offsprings)
    Officer
    2015-06-16 ~ 2019-02-20
    OF - director → CIF 0
  • 3
    Davis, Paul James
    Director born in June 1947
    Individual (6 offsprings)
    Officer
    2015-06-16 ~ 2019-02-20
    OF - director → CIF 0
parent relation
Company in focus

ORYGEN ANTIBODIES LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 1 ordinary share
12016-10-01 ~ 2017-09-30
Property, Plant & Equipment
9,709 GBP2017-09-30
8,160 GBP2016-09-30
Debtors
79,521 GBP2017-09-30
90,054 GBP2016-09-30
Cash at bank and in hand
351,206 GBP2017-09-30
393,543 GBP2016-09-30
Current Assets
430,727 GBP2017-09-30
483,597 GBP2016-09-30
Creditors
Current
95,584 GBP2017-09-30
185,647 GBP2016-09-30
Net Current Assets/Liabilities
335,143 GBP2017-09-30
297,950 GBP2016-09-30
Total Assets Less Current Liabilities
344,852 GBP2017-09-30
306,110 GBP2016-09-30
Creditors
Non-current
-250,000 GBP2017-09-30
-250,785 GBP2016-09-30
Net Assets/Liabilities
93,007 GBP2017-09-30
55,325 GBP2016-09-30
Equity
Called up share capital
100 GBP2017-09-30
100 GBP2016-09-30
Retained earnings (accumulated losses)
92,907 GBP2017-09-30
55,225 GBP2016-09-30
Equity
93,007 GBP2017-09-30
55,325 GBP2016-09-30
Average Number of Employees
102016-10-01 ~ 2017-09-30
102015-06-16 ~ 2016-09-30
Property, Plant & Equipment - Gross Cost
Motor vehicles
7,700 GBP2017-09-30
7,700 GBP2016-09-30
Computers
1,493 GBP2017-09-30
858 GBP2016-09-30
Property, Plant & Equipment - Gross Cost
12,593 GBP2017-09-30
8,558 GBP2016-09-30
Plant and equipment
3,400 GBP2017-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
2,045 GBP2017-09-30
160 GBP2016-09-30
Computers
577 GBP2017-09-30
238 GBP2016-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,884 GBP2017-09-30
398 GBP2016-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
262 GBP2016-10-01 ~ 2017-09-30
Motor vehicles
1,885 GBP2016-10-01 ~ 2017-09-30
Computers
339 GBP2016-10-01 ~ 2017-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
2,486 GBP2016-10-01 ~ 2017-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
262 GBP2017-09-30
Property, Plant & Equipment
Plant and equipment
3,138 GBP2017-09-30
Motor vehicles
5,655 GBP2017-09-30
7,540 GBP2016-09-30
Computers
916 GBP2017-09-30
620 GBP2016-09-30
Trade Debtors/Trade Receivables
Current
47,618 GBP2017-09-30
75,852 GBP2016-09-30
Amount of value-added tax that is recoverable
Current
579 GBP2017-09-30
Prepayments/Accrued Income
Current
31,324 GBP2017-09-30
14,202 GBP2016-09-30
Debtors
Current, Amounts falling due within one year
79,521 GBP2017-09-30
90,054 GBP2016-09-30
Trade Creditors/Trade Payables
Current
45,820 GBP2017-09-30
45,591 GBP2016-09-30
Corporation Tax Payable
Current
9,332 GBP2017-09-30
23,016 GBP2016-09-30
Other Taxation & Social Security Payable
Current
4,811 GBP2017-09-30
2,933 GBP2016-09-30
Other Creditors
Current
214 GBP2017-09-30
Accrued Liabilities/Deferred Income
Current
9,254 GBP2017-09-30
50,925 GBP2016-09-30
Accrued Liabilities
Current
26,153 GBP2017-09-30
62,119 GBP2016-09-30
Other Creditors
Non-current
250,000 GBP2017-09-30
250,785 GBP2016-09-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
36,733 GBP2017-09-30
36,733 GBP2016-09-30
Between one and five year
36,733 GBP2016-09-30
All periods
36,733 GBP2017-09-30
73,466 GBP2016-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10,000 shares2017-09-30
  • ORYGEN ANTIBODIES LIMITED
    Info
    Registered number SC508543
    60 Constitution Street, Edinburgh EH6 6RR
    Private Limited Company incorporated on 2015-06-16 and dissolved on 2020-01-23 (4 years 7 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.